Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Monia

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Ciba Foundation Symposium|January 1, 1997
First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinaseB P Monia
Anti-Cancer Drug Design|July 1, 1997
First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studiesB P Monia
Nature Medicine|February 4, 1999
Anti-tumor activity of C-raf antisense--correctionB P Monia
Idrugs : the Investigational Drugs Journal|May 10, 2008
Antisense therapy for cancerR M Orr, B P Monia
Biochimica Et Biophysica Acta|May 12, 2000
Novel mechanisms for antisense-mediated regulation of gene expressionB F Baker, B P Monia
Methods in Enzymology|November 24, 1999
Evaluation of biological role of c-Jun N-terminal kinase using an antisense approachC L Cioffi, B P Monia
International Journal of Cancer|June 8, 2000
Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor modelH Miyake, B P Monia, M E Gleave
Cancer Investigation|October 19, 2000
Antisense approaches for the treatment of cancerB P Monia, J Holmlund, F A Dorr
Trends in Pharmacological Sciences|March 31, 2000
Elucidating cell signaling mechanisms using antisense technologyE Koller, W A Gaarde, B P Monia
The Journal of Biological Chemistry|March 31, 1995
Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotidesJ L Duff, B P Monia, B C Berk
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Ciba Foundation Symposium|January 1, 1997
First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinaseB P Monia
Anti-Cancer Drug Design|July 1, 1997
First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studiesB P Monia
Nature Medicine|February 4, 1999
Anti-tumor activity of C-raf antisense--correctionB P Monia
Idrugs : the Investigational Drugs Journal|May 10, 2008
Antisense therapy for cancerR M Orr, B P Monia
Biochimica Et Biophysica Acta|May 12, 2000
Novel mechanisms for antisense-mediated regulation of gene expressionB F Baker, B P Monia
Methods in Enzymology|November 24, 1999
Evaluation of biological role of c-Jun N-terminal kinase using an antisense approachC L Cioffi, B P Monia
International Journal of Cancer|June 8, 2000
Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor modelH Miyake, B P Monia, M E Gleave
Cancer Investigation|October 19, 2000
Antisense approaches for the treatment of cancerB P Monia, J Holmlund, F A Dorr
Trends in Pharmacological Sciences|March 31, 2000
Elucidating cell signaling mechanisms using antisense technologyE Koller, W A Gaarde, B P Monia
The Journal of Biological Chemistry|March 31, 1995
Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotidesJ L Duff, B P Monia, B C Berk
Pageof 8